We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Zevra Therapeutics
ZVRA
$578M
| $220K | ﹤0.01% |
+17,153
| New | +$184K |
|
2402
Corcept Therapeutics
CORT
$9.98B
| $219K | ﹤0.01% |
9,941
-36,337
| -79% | -$809K |
|
2403
Four Corners Property Trust
FCPT
$2.89B
| $219K | ﹤0.01% |
+7,917
| New | +$224K |
|
|
CHS
2404
DELISTED
Chicos FAS, Inc.
CHS
| $219K | ﹤0.01% |
+33,229
| New | +$143K |
|
|
HYFT
2405
MindWalk Holdings
HYFT
$60.7M
| $218K | ﹤0.01% |
36,259
+2,836
| +8% | +$24K |
|
|
EXAS
2406
DELISTED
Exact Sciences
EXAS
| $216K | ﹤0.01% |
1,736
-25,014
| -94% | -$2.99M |
|
2407
Heartland Express
HTLD
$1.01B
| $216K | ﹤0.01% |
12,636
+160
| +1% | +$2.96K |
|
2408
Marqeta
MQ
$1.93B
| $216K | ﹤0.01% |
+1,920
| New | +$229K |
|
|
MTA
2409
Metalla Royalty & Streaming
MTA
$689M
| $213K | ﹤0.01% |
24,908
-10,318
| -29% | -$100K |
|
2410
Barings BDC
BBDC
$869M
| $211K | ﹤0.01% |
20,017
-23,719
| -54% | -$248K |
|
2411
PUT
Walmart Inc
WMT
$909B
| $211K | ﹤0.01% |
4,500
-129,300
| -97% | -$6.02M |
|
2412
WisdomTree
WT
$2.79B
| $210K | ﹤0.01% |
+33,876
| New | +$223K |
|
2413
Milestone Scientific
MLSS
$33.3M
| $209K | ﹤0.01% |
85,284
-26,668
| -24% | -$64.7K |
|
2414
Walt Disney
DIS
$171B
| $208K | ﹤0.01% |
1,182
-104,940
| -99% | -$18.9M |
|
|
B
2415
PUT
Barrick Mining
B
$60.9B
| $207K | ﹤0.01% |
10,000
-5,300
| -35% | -$119K |
|
2416
Cencora
COR
$62B
| $206K | ﹤0.01% |
+1,796
| New | +$212K |
|
2417
Seneca Foods Class A
SENEA
$1.15B
| $206K | ﹤0.01% |
+4,029
| New | +$194K |
|
2418
Seagate
STX
$174B
| $206K | ﹤0.01% |
2,341
-5,064
| -68% | -$456K |
|
|
CLDR
2419
DELISTED
Cloudera, Inc.
CLDR
| $205K | ﹤0.01% |
+12,903
| New | +$176K |
|
|
IH
2420
iHuman
IH
$71.6M
| $203K | ﹤0.01% |
+19,660
| New | +$217K |
|
2421
ReposiTrak
TRAK
$160M
| $203K | ﹤0.01% |
+36,878
| New | +$210K |
|
|
YSG
2422
Yatsen Holding
YSG
$317M
| $203K | ﹤0.01% |
+4,325
| New | +$224K |
|
|
ERUS
2423
DELISTED
iShares MSCI Russia ETF
ERUS
| $203K | ﹤0.01% |
+4,588
| New | +$192K |
|
2424
908 Devices
MASS
$312M
| $202K | ﹤0.01% |
5,221
-51,549
| -91% | -$2.33M |
|
2425
Hercules Capital
HTGC
$2.99B
| $201K | ﹤0.01% |
+11,766
| New | +$201K |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.